Page last updated: 2024-09-03

fullerene c60 and Carcinoma, Ductal, Breast

fullerene c60 has been researched along with Carcinoma, Ductal, Breast in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baltić, VV; Bogdanović, G; Canadanović-Brunet, J; Dordević, A; Kojić, V; Vojinović-Miloradov, M1

Other Studies

1 other study(ies) available for fullerene c60 and Carcinoma, Ductal, Breast

ArticleYear
Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity.
    Toxicology in vitro : an international journal published in association with BIBRA, 2004, Volume: 18, Issue:5

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Electron Spin Resonance Spectroscopy; Female; Fullerenes; Humans; Hydrogen Peroxide; Hydroxyl Radical; Iron; Spin Trapping

2004